Daiwa Securities Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Buy
33,893
+1,827
+6% +$168K 0.01% 582
2025
Q4
$2.88M Buy
32,066
+1,100
+4% +$104K 0.01% 579
2025
Q3
$3.05M Buy
30,966
+1,077
+4% +$107K 0.01% 547
2025
Q2
$2.73M Buy
29,889
+1,511
+5% +$146K 0.01% 559
2025
Q1
$3.21M Buy
28,378
+1,748
+7% +$187K 0.01% 483
2024
Q4
$2.81M Buy
26,630
+1,497
+6% +$161K 0.01% 514
2024
Q3
$2.71M Buy
25,133
+1,618
+7% +$177K 0.01% 515
2024
Q2
$2.55M Buy
23,515
+2,698
+13% +$318K 0.01% 499
2024
Q1
$2.75M Sell
20,817
-2,102
-9% -$263K 0.02% 462
2023
Q4
$2.79M Buy
22,919
+1,368
+6% +$153K 0.02% 436
2023
Q3
$2.42M Buy
21,551
+4,857
+29% +$617K 0.02% 450
2023
Q2
$2.43M Buy
16,694
+805
+5% +$109K 0.02% 447
2023
Q1
$2.05M Buy
15,889
+1,226
+8% +$154K 0.01% 487
2022
Q4
$1.87M Buy
14,663
+713
+5% +$82.7K 0.01% 489
2022
Q3
$1.46M Buy
13,950
+521
+4% +$57.2K 0.01% 534
2022
Q2
$1.41M Buy
13,429
+513
+4% +$60.9K 0.01% 551
2022
Q1
$1.65M Buy
12,916
+265
+2% +$31.9K 0.01% 556
2021
Q4
$1.56M Buy
12,651
+520
+4% +$68.1K 0.01% 573
2021
Q3
$1.72M Buy
12,131
+545
+5% +$80.2K 0.01% 531
2021
Q2
$1.81M Sell
11,586
-28
-0.2% -$4.54K 0.01% 479
2021
Q1
$1.8M Buy
11,614
+1,075
+10% +$167K 0.01% 458
2020
Q4
$1.58M Buy
10,539
+175
+2% +$24.7K 0.01% 457
2020
Q3
$1.37M Buy
10,364
+827
+9% +$108K 0.01% 428
2020
Q2
$936K Hold
9,537
0.02% 376
2020
Q1
$936K Buy
9,537
+206
+2% +$27K 0.01% 484
2019
Q4
$1.36M Sell
9,331
-206
-2% -$28.4K 0.01% 441
2019
Q3
$1.27M Buy
9,537
+1,387
+17% +$179K 0.01% 447
2019
Q2
$932K Sell
8,150
-435
-5% -$50.9K 0.01% 504
2019
Q1
$1.06M Buy
8,585
+257
+3% +$29.2K 0.01% 461
2018
Q4
$839K Buy
8,328
+693
+9% +$77.9K 0.01% 486
2018
Q3
$975K Buy
7,635
+613
+9% +$72.9K 0.01% 504
2018
Q2
$760K Buy
7,022
+206
+3% +$22.4K 0.01% 543
2018
Q1
$722K Buy
6,816
+363
+6% +$42.2K 0.01% 545
2017
Q4
$756K Sell
6,453
-738
-10% -$83.5K 0.01% 540
2017
Q3
$818K Sell
7,191
-380
-5% -$43.9K 0.01% 486
2017
Q2
$944K Buy
7,571
+670
+10% +$79.4K 0.01% 461
2017
Q1
$818K Buy
6,901
+4
+0.1% +$453 0.01% 492
2016
Q4
$691K Buy
6,897
+1,850
+37% +$198K ﹤0.01% 478
2016
Q3
$637K Buy
5,047
+154
+3% +$19K ﹤0.01% 471
2016
Q2
$572K Buy
4,893
+361
+8% +$40.9K ﹤0.01% 470
2016
Q1
$469K Buy
4,532
+412
+10% +$39.9K ﹤0.01% 496
2015
Q4
$410K Hold
4,120
﹤0.01% 516
2015
Q3
$376K Hold
4,120
﹤0.01% 546
2015
Q2
$437K Hold
4,120
﹤0.01% 559
2015
Q1
$470K Hold
4,120
﹤0.01% 470
2014
Q4
$454K Sell
4,120
-412
-9% -$43.4K ﹤0.01% 443
2014
Q3
$442K Hold
4,532
﹤0.01% 433
2014
Q2
$457K Sell
4,532
-412
-8% -$40.2K ﹤0.01% 421
2014
Q1
$454K Sell
4,944
-206
-4% -$19K ﹤0.01% 413
2013
Q4
$466K Hold
5,150
﹤0.01% 397
2013
Q3
$411K Sell
5,150
-206
-4% -$16.2K ﹤0.01% 440
2013
Q2
$390K Buy
+5,356
New +$400K ﹤0.01% 477

Other funds holding ZBH

Daiwa Securities Group's ZBH Position: Q1 2026 in Review

Daiwa Securities Group increased its Zimmer Biomet (ZBH) stake by 5.7% in Q1 2026, buying an estimated $168K and bringing the position to 33,893 shares worth $3.06M. The position accounts for 0.01% of the portfolio, ranked #582.

Daiwa Securities Group first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.21M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Daiwa Securities Group held 33,893 shares of Zimmer Biomet worth $3.06M as of Q1 2026.
  • Daiwa Securities Group bought 1,827 Zimmer Biomet shares in Q1 2026, an estimated $168K.
  • Zimmer Biomet made up 0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #582 holding.
  • Daiwa Securities Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Daiwa Securities Group's Zimmer Biomet position peaked at $3.21M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.